Edwards Larry Todd sold ARQT
October 2, 2025 · Form 4 insider transaction
Edwards Larry Todd sold 297 shares of Arcutis Biotherapeutics, Inc. at $20.78 per share, a transaction worth $6.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units granted on February 22, 2024.; The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $20.5593 to $20.995, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.; Includes 724 shares purchased under the Issuer's Employee Stock Purchase Plan on May 31, 2025.